Back to Search
DAVID BOL, PHARMD
PHARMD
Pharmacist
NPI: 1154900918Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PH61072771(WA)
Research & Publications (13)
Gene expression profiling in the discovery, optimization and development of novel drugs: one universal screening platform.
PMID 16515402·Pharmacogenomics·2006
6-review
A phase I dose-ranging study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of AVN944, an IMPDH inhibitor, in healthy male volunteers.
PMID 18971325·J Clin Pharmacol·2009
3-trial
Constitutively active receptor tyrosine kinases as oncogenes in preclinical models for cancer therapeutics.
PMID 16818516·Mol Cancer Ther·2006
7-preclinical
Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase kinase-induced skin tumorigenesis.
PMID 15695401·Cancer Res·2005
7-preclinical
Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor.
PMID 15867374·Cancer Res·2005
7-preclinical
Apoptotic and cytostatic farnesyltransferase inhibitors have distinct pharmacology and efficacy profiles in tumor models.
PMID 15173010·Cancer Res·2004
7-preclinical
Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis.
PMID 12941801·Cancer Res·2003
7-preclinical
Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells.
PMID 12796723·J Cereb Blood Flow Metab·2003
7-preclinical
Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development.
PMID 11980643·Cancer Res·2002
7-preclinical
Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities.
PMID 12190313·J Med Chem·2002
7-preclinical
Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice.
PMID 10737798·Proc Natl Acad Sci U S A·2000
7-preclinical
Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion.
PMID 10749124·Cancer Res·2000
7-preclinical
Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
PMID 10980598·Oncogene·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1450 1ST AVE SW
QUINCY, WA 98848 - Phone
- (509) 787-0735
Quick Facts
- NPI
- 1154900918
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile